Calliditas Therapeutics AB (publ) (CALT) Institutional Ownership → Major Elon Musk Crypto Leak Revealed (From Crypto 101 Media) (Ad) Free CALT Stock Alerts $21.01 -0.48 (-2.23%) (As of 05:21 PM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Calliditas Therapeutics AB (publ) (NASDAQ:CALT)CurrentInstitutional OwnershipPercentage2.83%Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$515,751.20Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$146,504.64 Get CALT Insider Trade Alerts Want to know when executives and insiders are buying or selling Calliditas Therapeutics AB (publ) stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CALT Institutional Buying and Selling by Quarter Ad Insiders ExposedThis consistently signaled gains of 453%... 610%... and even 1036%...It doesn’t happen often, but occasionally, something completely unique comes across my radar. In this case, I’m talking about legal “Insider Trading”. Traders who have consistently signaled 453% … 610% .. and even 1036%... gains. And until now they have been doing it completely under the radar. In an upcoming interview I am revealing the strategy behind this gold-mine and how you can piggy back their every trade.Register for the imminent briefing here. Calliditas Therapeutics AB (publ) Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024Optiver Holding B.V.980$25K0.0%N/A0.003% 5/15/2023Ironwood Investment Management LLC27,795$0.67M0.4%+5.6%0.093% 5/15/2023Deutsche Bank AG90,509$2.17M0.0%+26.5%0.304% 5/11/2023Optiver Holding B.V.5,029$0.12M0.0%-54.9%0.017% 2/10/2023Optiver Holding B.V.11,141$0.20M0.0%-11.8%0.037% 2/9/2023 HBK Sorce Advisory LLC90,000$0.10M0.0%+100.0%0.302% Get the Latest News and Ratings for CALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Calliditas Therapeutics AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 1/31/2023Ironwood Investment Management LLC26,309$0.45M0.3%-8.5%0.088% 11/16/2022Jane Street Group LLC12,491$0.19M0.0%+7.6%0.042% 11/14/2022Optiver Holding B.V.12,625$0.19M0.0%+1,304.3%0.043% 11/14/2022 HBK Sorce Advisory LLC45,000$50K0.0%N/A0.152% 11/10/2022Tower Research Capital LLC TRC 3,357$51K0.0%+1,270.2%0.011% 5/17/2022Jane Street Group LLC11,543$0.22M0.0%N/A0.044% 5/10/2022Ironwood Investment Management LLC28,762$0.55M0.3%+5.5%0.110% 2/10/2022Ironwood Investment Management LLC27,267$0.68M0.3%-2.0%0.104% 11/12/2021Ironwood Investment Management LLC27,836$0.60M0.3%+75.2%0.106% 8/27/2021Endurant Capital Management LP144,393$4.25M1.2%+1.5%0.552% 8/12/2021Advisory Services Network LLC3,369$99K0.0%N/A0.013% 8/11/2021Deutsche Bank AG71,531$2.11M0.0%+1.8%0.286% 7/31/2021NEXT Financial Group Inc4,458$0.13M0.0%N/A0.018% 5/19/2021Hillhouse Capital Advisors LTD.944,716$26.10M0.3%-9.8%3.783% 5/18/2021Millennium Management LLC15,570$0.43M0.0%-24.0%0.062% 5/18/2021Tudor Investment Corp Et Al13,782$0.38M0.0%N/A0.055% 5/18/2021Citadel Advisors LLC9,571$0.26M0.0%N/A0.038% 5/17/2021Endurant Capital Management LP142,323$3.92M1.0%N/A0.570% 2/17/2021Jane Street Group LLC7,557$0.26M0.0%-26.5%0.032% 2/13/2021Hillhouse Capital Advisors LTD.1,047,687$35.61M0.3%+199.3%4.371% 12/9/2020Pentwater Capital Management LP61,084$1.47M0.0%-7.4%0.255% 11/17/2020Jane Street Group LLC10,278$0.24M0.0%+13.8%0.043% 11/17/2020Logos Global Management LP550,000$13.20M1.7%+83.3%2.295% 11/16/2020Point72 Asset Management L.P.257,892$6.19M0.0%-42.7%1.076% 11/6/2020BlackRock Inc.1,191$29K0.0%N/A0.005% (Data available from 1/1/2016 forward) CALT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CALT shares? During the previous two years, the following institutional investors and hedge funds held shares of Calliditas Therapeutics AB (publ) shares: Deutsche Bank AG ($2.17M), Ironwood Investment Management LLC ($0.67M), Jane Street Group LLC ($0.19M), HBK Sorce Advisory LLC ($0.10M), and Tower Research Capital LLC TRC ($51K), Optiver Holding B.V. ($25K).Learn more on CALT's institutional investors. What percentage of Calliditas Therapeutics AB (publ) stock is owned by institutional investors? 2.83% of Calliditas Therapeutics AB (publ) stock is owned by institutional investors. Learn more on CALT's institutional investor holdings. Which institutional investors have been buying Calliditas Therapeutics AB (publ) stock? The following institutional investors have purchased Calliditas Therapeutics AB (publ) stock in the last 24 months: HBK Sorce Advisory LLC ($90K), Deutsche Bank AG ($18.98K), Optiver Holding B.V. ($12.71K), Jane Street Group LLC ($12.43K), Tower Research Capital LLC TRC ($3.11K), and Ironwood Investment Management LLC ($2.98K). How much institutional buying is happening at Calliditas Therapeutics AB (publ)? Institutional investors have bought a total of 140,206 shares in the last 24 months. This purchase volume represents approximately $2.45M in transactions. Which Calliditas Therapeutics AB (publ) major shareholders have been selling company stock? The following institutional investors have sold Calliditas Therapeutics AB (publ) stock in the last 24 months: Optiver Holding B.V. ($7.60K), and Ironwood Investment Management LLC ($2.43K). How much institutional selling is happening at Calliditas Therapeutics AB (publ)? Institutional investors have sold a total of 10,029 shares in the last 24 months. This volume of shares sold represents approximately $0.21M in transactions. Related Companies: Olema Pharmaceuticals Major Shareholders Y-mAbs Therapeutics Major Shareholders CureVac Major Shareholders Fulcrum Therapeutics Major Shareholders Applied Therapeutics Major Shareholders Nurix Therapeutics Major Shareholders AnaptysBio Major Shareholders Lexicon Pharmaceuticals Major Shareholders Savara Major Shareholders OPKO Health Major Shareholders This page (NASDAQ:CALT) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaFed launches fourth dollar overhaulStansberry ResearchBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the MarketsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calliditas Therapeutics AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.